60 Degrees Pharmaceuticals, Inc. (SXTP)
60 Degrees Pharmaceuticals will go public soon. The estimated IPO date is June 1, 2023.
IPO Price Range
$4.30 - $6.30
Shares Offered
1,415,095
Deal Size
$7.50M
Company Description
60 Degrees Pharmaceuticals is a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases.
We have successfully achieved regulatory approval of Arakoda, a malaria preventative treatment that has been on the market since late 2019.
Currently, 60P’s pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.
60 Degrees Pharmaceuticals, Inc.
Country | United States |
Founded | 2010 |
IPO Date | Jun 1, 2023 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2 |
CEO | Geoffrey S. Dow |
Contact Details
Address:
1025 Connecticut Avenue NW Suite 1000 Washington, DC, 20036 United States | |
Phone | (202) 327-5422 |
Website | 60degreespharma.com |
Stock Details
Ticker Symbol | SXTP |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001946563 |
Employer ID | 45-2406880 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Geoffrey Dow | Chief Executive Officer, President and Director |
Tyrone Miller | Treasurer |
Bryan Smith | Chief Medical Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 24, 2023 | D | Notice of Exempt Offering of Securities |
May 19, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Apr 28, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Apr 3, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jan 31, 2023 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Dec 23, 2022 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Dec 5, 2022 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Oct 18, 2022 | DRS | [Cover] Draft Registration Statement |